OMRON (FRA:OMR) Research & Development: €260 Mil (TTM As of Mar. 2026)


FRA:OMR OMRON Corp FRA:OMR
75 GF Score
Price €31.94
GF Value €27.47
! 9 Warning Signs
View Full Analysis

What is OMRON Research & Development?

OMRON FRA:OMR 75 Research & Development is €260 Mil as of Mar. 2026. GuruFocus rates FRA:OMR with a GF Score™ of 75/100 and a GF Value™ of €27.47. The stock has 9 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. OMRON's Research & Development for the three months ended in Mar. 2026 was €39 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €260 Mil.

OMRON  (FRA:OMR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

OMRON Research & Development Related Terms

OMRON Research & Development Historical Data

* Premium members only.

The historical data trend for OMRON's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OMRON Research & Development Chart

OMRON Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 339.05 350.65 307.92 247.98 248.94

OMRON Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 73.32 74.87 75.86 70.69 38.81
FRA:OMR
75GF Score
OMRON Corp FRA:OMR
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OMRON Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €260 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €260 Mil mean?
OMRON (FRA:OMR) has a Research & Development of €260 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on OMRON and its competitors.
Is OMRON's Research & Development too high?
OMRON's current Research & Development is €260 Mil. Overall, OMRON has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does OMRON's Research & Development compare to APH and GLW?
OMRON's Research & Development of €260 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Hardware company?
A good Research & Development depends on the Hardware industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on OMRON and its competitors. OMRON's current Research & Development is €260 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OMRON stock overvalued right now?
OMRON (FRA:OMR) has a current Research & Development of €260 Mil. The stock's GF Value™ is €27.47, compared to a current price of €31.94 — trading 16.3% above its estimated fair value. The current Research & Development is €260 Mil. OMRON's overall GF Score™ is 75/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For OMRON (FRA:OMR), the current Research & Development is €260 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OMRON (FRA:OMR) Overvalued in 2026?

Based on GuruFocus' analysis, OMRON stock appears to be overvalued. The current stock price of €31.94 is trading 16.3% above its estimated GF Value™ of €27.47.

Key valuation signals for FRA:OMR:

  • Research & Development: €260 Mil
  • GF Value™: €27.47 vs. price of €31.94 (16.3% above fair value)
  • GF Score™: 75/100 with 9 warning signs

No single metric tells the full story. See the FRA:OMR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OMRON Business Description

Address 801 Minamifudodocho, Shiokoji-dori Horikawa-higashiiru, Shimogyo-ku, Kyoto, JPN, 600-8234
Omron Corporation, founded in 1933 and headquartered in Kyoto, Japan, is a leading global manufacturer specializing in automation, sensing, and control technologies. The company operates through diverse business segments, including industrial automation, healthcare, social systems, device & module solutions, and data solutions. Its offerings range from factory automation equipment, electronic components, and social infrastructure systems to medical devices and healthcare data analytics. With operations across Japan, Asia, the Americas, Europe, and other regions, Omron plays a pivotal role in advancing industrial productivity, healthcare innovation, and social infrastructure, guided by its mission of "improving lives and contributing to a better society."
75GF Score

Get the complete analysis for FRA:OMR

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€31.94
Price
€27.47
GF Value